GRIP: Gordian Robotic Integrated Port Closure Study
NCT: NCT07649915 · NOT_YET_RECRUITING
Brief Summary
The GRIP (Gordian Robotic Integrated Port Closure) Study is a prospective, single-arm feasibility study evaluating the use of the TroClose™ 1200 device for closure of da Vinci® 12 mm robotic assistant port sites following robotic-assisted surgical procedures. TroClose™ 1200 is an FDA-cleared medical device designed to facilitate fascial closure of laparoscopic and robotic access ports. The device deploys anchors and suture at the beginning of the procedure, allowing closure to be completed at the end of surgery without the need for additional needle passage or specialized closure instruments. The purpose of this study is to assess the safety, feasibility, procedural performance, and clinical outcomes associated with use of the device in patients undergoing robotic-assisted surgery. Study assessments will include successful port-site closure, device-related adverse events, post-operative complications, and short-term follow-up evaluations. Approximately 26 adult participants undergoing robotic-assisted surgical procedures at Allegheny Health Network will be enrolled.
Frequently Asked Questions
What is GRIP: Gordian Robotic Integrated Port Closure Study?
GRIP: Gordian Robotic Integrated Port Closure Study is a clinical trial registered under NCT07649915. Current status: NOT_YET_RECRUITING.
What is the status of NCT07649915?
The current status of NCT07649915 (GRIP: Gordian Robotic Integrated Port Closure Study) is: NOT_YET_RECRUITING.
When did GRIP: Gordian Robotic Integrated Port Closure Study start?
GRIP: Gordian Robotic Integrated Port Closure Study started on 2026-06-30.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.